Why the study?
Randomized controlled trials have reported contrasting results regarding reverse left ventricular remodeling after SGLT2i therapy in patients with heart failure.
Do SGLT2 inhibitors improve left ventricular remodeling in outpatients with heart failure?
Population
1385 HF outpatients across 9 RCTs
Comparison
SGLT2i administration vs control
Design
Meta-analysis of RCTs
Authors
Loading...
SGLT2i promote reverse LV remodeling in HFrEF outpatients; reinforces and extends evidence from prior heterogeneous RCTs.
Do SGLT2 inhibitors improve left ventricular remodeling in outpatients with heart failure?
SGLT2 inhibitors significantly reverse cardiac remodeling and improve left ventricular systolic function and mass in heart failure patients, particularly those with HFrEF.
Carluccio et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: